Abstract

Tramadol, an opioid analgesic, is used to relieve mild to moderately severe pain. It initially binds to the opioid receptor, and then it lessens the reactivity of norepinephrine and serotonin. The polymers EC, HPMC K4M, and CAP were encapsulated using the emulsion solvent evaporation process, and formulation characterization was completed. The obtained microspheres were round and white. The phosphate buff er with a pH of 6.8 was used for the in vitro investigations of the microspheres, which were carried out for 8 hours at a temperature of 37????C and 100 rpm in a 900 mL USP basket-type dissolution rate test equipment. Formulation F3 entrapped the most medication, but Formulation F6 displayed a greater yield. The impact of the polymer’s type and composition on the medication release was evident. The tramadol hydrochloride microsphere’s regulated drug release results in increased plasma drug content as well as better-quality bioavailability

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call